Six of the world’s leading health research centres have joined forces to form a global alliance that seeks to strengthen international academic and not-for-profit drug development. The aim of the Global Alliance of Leading Drug Discovery and Development Centres, which consists of organisations from Europe and North America, is to accelerate the translation of academic research into usable medicines and therapies.
The founding organisations include:
- The Centre for Drug Research and Development (CDRD), Canada
- Lead Discovery Centre (LDC), Germany
- The Scripps Research Institute, Scripps Florida, United States
- The Centre for Drug Design and Discovery (CD3), KU Leuven R&D, Belgium
- Medical Research Council (MRC) Technology, United Kingdom
- Cancer Research Technology (CRT), United Kingdom
New Global Alliance Aims To Speed Up Academic Drug Discovery
This type of global alliance is sure to boost the speed of drug discovery so make development more efficient to meet the needs of patients more fully.
ReplyDelete